Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
The market could potentially see the emergence of new biotech industry leaders. Since the year started, Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT), two clinical-stage drugmakers, have seen their shares skyrocket. The reason? Both companies announced promising clinical progress for their leading pipeline candidates.
While there's still some way to go before launching their products, it's hard to argue with the results both Viking and Summit have already achieved. And if they can get that far, they could deliver excellent returns in the long run. But which one looks more attractive?
Source Fool.com
Viking Therapeutics Inc Stock
€56.04
-1.620%
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Viking Therapeutics Inc.
As a result the target price of 110 € shows a very positive potential of 96.29% compared to the current price of 56.04 € for Viking Therapeutics Inc.
